Raymond James Sees 'Lingering Risks' At OraSure, Downgrades To Market Perform


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Shares of OraSure Technologies, Inc. (NASDAQ: OSUR) are up 20 percent year-to-date. Raymond James’ Nicholas Jansen downgraded the rating for the company from Outperform to Market Perform, saying the shares were within 3 percent of the previous price target of $8.

Factors Driving Outperformance

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Analyst Nicholas Jansen mentioned that OraSure’s outperformance was driven by upside to the company’s 4Q and 1Q numbers, growing profitability, and the potential Zika opportunity.

Jansen believes that OraSure’s strength lies in its DNA Genotek franchise, which contributes 25 percent of its revenues. He added that more options, including work on Ebola and Zika, were available for the company and could lead to modest appreciation in its shares.

Risks To Future Performance

While OraSure’s partnership with AbbVie Inc (NYSE: ABBV) is on a solid footing, the challenges facing the Hepatitis C market have increased, thus affecting the performance of AbbVie’s drug.

“The five-plus year contract that was signed in June 2014 has its first six-month notice exit clause at the end of this month, which is worth monitoring,” Jansen added. An end to this relationship implies OraSure would no longer be profitable in the short term.

Other risks facing the company include ongoing competitive HIV pressure, and “likely peaked near-term gross margin trends.” These factors along with limited visibility into more meaningful revenue upside in 2016 warrant a more balanced risk/reward at the current levels, the analyst commented.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorBiotechDowngradesHealth CareAnalyst RatingsGeneralEbolaGenotekNicholas JansenRaymond JamesZika